STAAR Surgical Company (STAA) Q4 FY25 Earnings Call

Inventory normalization, U.S. momentum, and cost discipline support recovery, but management withheld guidance and expects growth below prior peaks.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-03-05
Length50 minutes
EPS$-0.13
Revenue$57.8M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All STAA earnings ยท Back to STAA overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.